A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia

[1]  Lin He,et al.  Significant Association Between the Genetic Variations in the 5′ End of the N-Methyl-D-Aspartate Receptor Subunit Gene GRIN1 and Schizophrenia , 2006, Biological Psychiatry.

[2]  L. Abramova,et al.  Polymorphism in the 5′-promoter region of serine racemase gene in schizophrenia , 2006, Molecular Psychiatry.

[3]  Lin He,et al.  An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray , 2005, European Journal of Human Genetics.

[4]  K. Hashimoto,et al.  Identification of Multiple Serine Racemase (SRR) mRNA Isoforms and Genetic Analyses of SRR and DAO in Schizophrenia and d-Serine Levels , 2005, Biological Psychiatry.

[5]  C. Chiu,et al.  Characterization and localization of a human serine racemase. , 2004, Brain research. Molecular brain research.

[6]  Bita Moghaddam,et al.  NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Hiroto Takahashi,et al.  Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits , 2002, Nature.

[8]  A. Morikawa,et al.  Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino acid oxidase activity. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[9]  R. Panizzutti,et al.  A new strategy to decrease N-methyl-d-aspartate (NMDA) receptor coactivation: Inhibition of d-serine synthesis by converting serine racemase into an eliminase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. de Miranda,et al.  Human serine racemase: moleular cloning, genomic organization and functional analysis. , 2000, Gene.

[11]  S H Snyder,et al.  Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K N Sheth,et al.  Purification of serine racemase: biosynthesis of the neuromodulator D-serine. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. V. Rayudu,et al.  Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A , 1998, Nature.

[14]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[15]  S. Furukawa,et al.  Reduction of NGF protein level in rat dorsal hippocampus following administration of kainic acid , 1992, Neuroscience Letters.

[16]  J. Olney,et al.  NMDA antagonist neurotoxicity: mechanism and prevention. , 1991, Science.

[17]  C. Ikonomidou,et al.  MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  G. Lynch,et al.  Contributions of quisqualate and NMDA receptors to the induction and expression of LTP. , 1988, Science.

[19]  G. Lynch,et al.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 , 1986, Nature.